Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Twist Bioscience Corp roe for the quarter ending 2026-06-30 was -30.67%, a change of -12.86% year-over-year.
Twist Bioscience Corp roe for the quarter ending 2026-03-31 was -17.86%, a change of 25.57% year-over-year.
Twist Bioscience Corp roe for the quarter ending 2025-12-31 was -16.79%, a change of 26.48% year-over-year.
Twist Bioscience Corp roe for the quarter ending 2025-09-30 was -16.42%, a change of 27.73% year-over-year.
Twist Bioscience Corp roe for fiscal 2025 was -16.42%, a change of 27.73% from fiscal 2024.
Twist Bioscience Corp roe for fiscal 2024 was -44.16%, a change of -11.34% from fiscal 2023.
Twist Bioscience Corp roe for fiscal 2023 was -32.82%, a change of -5.22% from fiscal 2022.
Twist Bioscience Corp roe for fiscal 2022 was -27.60%, a change of -1.41% from fiscal 2021.